FAP and cancer: Due to the unique overexpression and membrane localization of FAP on various cells within the GBM microenvironment, FAP is considered a potential molecular diagnostic biomarker, and FAP inhibitors (FAPIs) have been under investigation for PET imaging in several cancers [78], broadening the applications for noninvasive tumor diagnosis, grading stratification and planning for surgery and radiotherapy.